WST - West Pharmaceutical Services Inc. (WST) Q1 2024 Earnings Call Transcript
2024-04-25 17:42:08 ET
West Pharmaceutical Services, Inc. (WST)
Q1 2024 Earnings Conference Call
April 25, 2024, 9:00 AM ET
Company Participants
Quintin Lai - Vice President, Strategy and Investor Relations
Eric Green - President and Chief Executive Officer
Bernard Birkett - Senior Vice President, Chief Financial and Operations Officer
Conference Call Participants
Matt Larew - William Blair
Jacob Johnson - Stephens
Paul Knight - KeyBanc
Michael Ryskin - Bank of America
Justin Bowers - Deutsche Bank
David Windley - Jefferies
Larry Solow - CJS Securities
Presentation
Operator
Good day, and thank you for standing by. Welcome to West Pharmaceutical Services First Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] Please note that today's conference may be recorded.
I will now hand the conference over to your speaker host Quintin Lai, Vice President of Investor Relations. Please go ahead, sir.
Quintin Lai
Thank you, Olivia. Good morning, and welcome to West's first quarter 2024 conference call. We issued our financial results this morning and the release has been posted in the investors section on the company's website located at westpharma.com. This morning, we will review our financial results, provide an update on our business and present an updated financial outlook for the full year 2024. There is a slide presentation that accompanies today's call and a copy of that presentation is available on the investors section of our website.
On slide four is our safe harbor statement. Statements made by management on this call and in the accompanying presentation contain forward-looking statements within the meaning of U.S. federal securities law. These statements are based on our beliefs and assumptions, current expectations, estimates and forecasts. The company's future results are influenced by many factors beyond the control of the company. Actual results could differ materially from past results as well as those expressed or implied in any forward-looking statement made here. Please refer to today's press release as well as any other disclosures made by the company regarding the risks to which it is subject, including our 10-K, 10-Q and 8-K reports.
During today's call, management will make reference to non-GAAP financial measures, including organic sales growth, adjusted operating profit, adjusted operating profit margin and adjusted diluted EPS. The reconciliations and limitations of the non-GAAP financial measures to the most comparable financial results prepared in conformity to GAAP are provided in this morning's earnings release....
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript